Skip to main content

Advertisement

SpringerLink
Log in

Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients

  • Review Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gussow D, Ploegh H (1987) Soluble class I antigens: a conundrum with no solution? Immunol Today 8:220

    Article  Google Scholar 

  2. Calne RY, White HJ, Yoffa DE, Binns RM, Maginn RR, Herbertson RM, Millard PR, Molina VP, Davis DR (1967) Prolonged survival of liver transplants in the pig. Br Med J 2(550):487

    Google Scholar 

  3. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA (1969) Induction of immunological tolerance by porcine liver allografts. Nature 223(205):472

    CAS  PubMed  Google Scholar 

  4. Van Rood JJ, van Leeuwen A, van Santen MCT (1970) Anti HL-A2 inhibitor in normal human serum. Nature 226:366

    PubMed  Google Scholar 

  5. Charlton RK, Zmijewski CM (1970) Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science 170(958):636

    CAS  PubMed  Google Scholar 

  6. Schultz JS, Shreffler DC (1975) Studies on the serum fraction containing soluble inhibitors of anti-HL-A sera. Transplantation 16(3):205

    Google Scholar 

  7. Aster RH, Miskovich BH, Rodey GE (1973) Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction. Transplantation 16(3):205

    CAS  PubMed  Google Scholar 

  8. Jankowska-Gan E, Rhein T, Haynes LD, Geissler F, Mulder A, Kalayoglu M, Sollinger H, Burlingham WJ (1992) Human liver allograft acceptance and “tolerance assay”. II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH. Hum Immunol 63(10):862

    Article  Google Scholar 

  9. den Dulk M, Bishop GA (2003) Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation. Arch Immunol Ther Exp (Warsz) 51(1):29

    Google Scholar 

  10. Jendro M, Goronzy JJ, Weyand CM (1991) Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 8(4):289–296

    CAS  PubMed  Google Scholar 

  11. Aultman D, Adamashvili I, Yaturu K, Langford M, Gelder F, Gautreaux M, Ghali GE, McDonald J (1999) Soluble HLA in human body fluids. Hum Immunol 60(3):239–244

    Article  CAS  PubMed  Google Scholar 

  12. Dobbe LM, Starn NJ, Neefjes JJ, Giphart MJ (1988) Biochemical complexity of serum HLA class I molecules. Immunogenetics 27(3):203

    Article  CAS  PubMed  Google Scholar 

  13. Krangel MS (1986) Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163(5):1173

    Article  CAS  PubMed  Google Scholar 

  14. Krangel MS (1987) Two forms of HLA class I molecules in human plasma. Hum Immunol 20(2):155

    Article  CAS  PubMed  Google Scholar 

  15. Haga JA, She JX, Kao KJ (1991) Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion. J Biol Chem 266(6):3695

    CAS  PubMed  Google Scholar 

  16. Hiraki DD, See-Tho K, Filvaroff E, Krishnaswamy S, de Bello W, Taidi-Laskowski B, Grumet FC (1994) Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dirnerization. Hum Immunol 40(3):235

    Article  CAS  PubMed  Google Scholar 

  17. Lucas ZJ (1970) An assay for antibodies to histocompatibility antigens based on inhibition of radioiodine-labeled antibody binding. Transplantation 10(6):512

    CAS  PubMed  Google Scholar 

  18. Foschi GV, Manson LA (1970) Radioimmune assay for histocompatibility antigens. Nature 225(235):853

    CAS  Google Scholar 

  19. Miyakawa Y, Tanigaki N, Kreiter VP, Moore GE, Pressman D (1973) Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation 15(3):312

    CAS  PubMed  Google Scholar 

  20. Tanigaki N, Miyakawa Y, Yagi Y (1973) Radioiodinated soluble HLA antigens: HLA alloantigenic characterization and use in radioimmunoassay. J Immunol Methods 3(2):109

    Article  CAS  PubMed  Google Scholar 

  21. Giphart MJ, Doyer E, Bruning JW, Rood JJ (1975) The application of radiolabelled HLA antibodies in the detection of (soluble) transplantation antigens: an alternative for the microcytotoxicity test. J Immunol Methods 9(2):105

    Article  CAS  PubMed  Google Scholar 

  22. Ferreira A, Revilla Y, Bootello A, Gonzalez-Porque P (1983) Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods 65(3):373

    Google Scholar 

  23. Russo C, Pellegrino MA, Ferrone S (1983) A double-determinant immunoassay with monoclonal antibodies to the HLA-A, B, C complex. Transplant Proc 15:66

    Google Scholar 

  24. Sakaguchi K, Ono R, Tsujisaki M, Richiardi P, Carbonara A, Park MS, Tonai R, Terasaki PI, Ferrone S (1988) Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay. Hum Immunol 21(3):193

    Article  CAS  PubMed  Google Scholar 

  25. Comuzio S, Puppo P, Ruzzenenti R, Orlandini A, Grillo F, Brenci S, Lanza L, Scudeletti M, Indiveri F (1991) Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. J Clin Lab Anal 5(4):278

    CAS  PubMed  Google Scholar 

  26. Doxiadis I, Westhoff U, Grosse-Wilde H (1989) Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59(5):449

    Article  CAS  PubMed  Google Scholar 

  27. Gelder FB, McDonald JC, Landreneau MD, McMillan RM, Aultman DF (1991) Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg 213(6):591

    Google Scholar 

  28. McDonald JC, Gelder FB, Aultman DF, Landreneau MD, McMillan RW, Singh I, Sorrells D, Liou WH (1992) HLA in human serum: quantitation of class I by enzyme immunoassay. Transplantation 53(2):445

    CAS  PubMed  Google Scholar 

  29. Indiveri F, Wilson BS, Natali PG, Pellegrino MA, Ferrone S (1980) Immunogenicity of DR antigens isolated from body fluids. Transplant Proc 12(1):121

    CAS  PubMed  Google Scholar 

  30. Wu T, Lan J, Zhang H, Wang CR, Mao GC (2002) Detection of soluble HLA class I antigens by ELISA and determination of its reference value in population of Guangdong province. Di Yi Jun Yi Da Xue Xue Bao Yi K 22(10):931

    CAS  Google Scholar 

  31. Pellegrino MA, Russo C, Allison JP (1984) HLA antigens in serum. Methods Enzymol 108:614

    CAS  PubMed  Google Scholar 

  32. Westhoff U, Thinnes FP, Gotz H, Grosse-Wilde H (1991) Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 61(2):106

    CAS  PubMed  Google Scholar 

  33. Reisfeld RA, Allison JP, Ferrone S, Pellegrino MA, Poulik MD (1976) HL-A antigens in serum and urine: isolation, characterization, and immunogenic properties. Transplant Proc 8(2):173

    CAS  Google Scholar 

  34. Pellegrino MA, Ferrone S, Pellegrino AG, Oh SK, Reisfeld RA (1974) Evaluation of two sources of soluble HL-A antigens: platelets and serum. Eur J Immunol 4(4):250

    CAS  PubMed  Google Scholar 

  35. Adamashvilli IM, Fraser PM, McDonald JC (1996) Association of serum concentrations of soluble class I HLA with HLA allotypes. Transplantation 61(6):984

    Article  PubMed  Google Scholar 

  36. Adamashvilli I, Wolf R, Aultman D, Milford EL, Jaffe S, Hall V, Pressly T, Minagar A, Kelley R (2003) Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus. Rheumatol Int 23(6):294

    Article  PubMed  Google Scholar 

  37. Zavazava N, Wobst B, Ferstl R, Muller-Ruchholtz W (1994) Soluble MHC class I molecules in human body fluids. J Clin Lab Anal 8(6):432

    CAS  PubMed  Google Scholar 

  38. Nakanashi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K, Kosaka K (1993) Association of HLA-A24 with complete B-cell destruction in insulin-dependent diabetes mellitus. Diabetes 42:1086

    PubMed  Google Scholar 

  39. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K (1993) Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780

    CAS  PubMed  Google Scholar 

  40. Nakanishi K, Kobayashi T, Komatsu Y, Kogawa N, Hagihara M, Tsuji K (1993) Synchronous decline of serum-soluble HLA class I antigens and beta-cell function in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 85:246

    Google Scholar 

  41. Adamashvili I, McVie R, Gelder F, Gautreaux M, Jaramillo J, Roggero T, McDonald J (1997) Soluble HLA class I antigens in patients with type I diabetes and their family members. Hum Immunol 55(2):176–183

    Article  CAS  PubMed  Google Scholar 

  42. McDonald J, Adamashvili I, Hayes J, Aultman DF, Rhynes VK, Gelder FB (1994) Soluble HLA class II concentrations in normal individuals and transplant recipients: comparison with soluble class I concentrations. Transplantation 28:1268

    Google Scholar 

  43. Hagihara M, Shimura T, Yamamoto K, Takebe K, Munkhbat B, Tsuji K (1994) Soluble HLA class I and class II in Japanese. Hum Immunol 40(3):171

    Article  CAS  PubMed  Google Scholar 

  44. Weyand CM, Jendro M, Goronzy JJ (1991) Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 8(4):281

    CAS  PubMed  Google Scholar 

  45. Adamashvili I, Fraser PA, Milford EL, Sittig K, Gebel H, Zibari G, Pressly T, McDonald JC (2002) Soluble HLA-II expression in African-Americans. Inflamm Res 51(6):290

    CAS  PubMed  Google Scholar 

  46. Adamashvili IM, McDonald JC, Fraser PA, Milford EL, Pressly TA, Gelder FB (1995) Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol 22:1025

    CAS  PubMed  Google Scholar 

  47. Tsuchiya N, Shiota M, Yamaguchi A, Ito K (1996) Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 39(5):792

    CAS  PubMed  Google Scholar 

  48. Sakaguchi K, Koide N, Takenami T, Matsushima H, Takabatake H, Ferrone S, Tsuji T (1992) Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn 27(2):206

    CAS  PubMed  Google Scholar 

  49. Inostroza J, Munoz P, Espinoza R, Millaqueo L, Diaz P, Leiva L, Sorensen R (1997) Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis. Hum Immunol 40(3):179

    Article  Google Scholar 

  50. Inostroza J, Fertada J, Navarrete C, Sorensen RU (1997) Soluble histocompatibility class I antigens and beta 2-microglobulin in pregnant females and cord blood samples. Hum Immunol 54(1):63

    Article  CAS  PubMed  Google Scholar 

  51. Sandrin MS, Henning MM, Vaughan HA, McKenzie IF, Parish CR (1981) Serum Ia levels during tumor growth in mice and humans. J Natl Cancer Inst 66(2):279

    CAS  PubMed  Google Scholar 

  52. Shimura T, Hagihara M, Yamamoto K, Takebe K, Munkhbat B, Ogoshi K, Mitomi T, Nagamachi Y, Tsuji K (1994) Quantification of serum-soluble HLA class I antigens in patients with gastric cancer. Hum Immunol 40(3):183

    Article  CAS  PubMed  Google Scholar 

  53. Hagihara M, Shimura T, Takebe K, Munkhbat B, Hosoi K, Kagawa T, Watanabe N, Matsuzaki S, Yamamoto K, Sato K, Tsuji K (1997) Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 32:338–43

    Google Scholar 

  54. Filaci G, Contini P, Brenci S, Lanza L, Scudeletti M, Indiveri F, Puppo F (1995) Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 46(2):117

    CAS  PubMed  Google Scholar 

  55. Herlyn M, Lange B, Bennicelli J, Blaszczyk M, Guerry D 4th, Koprowski H (1984) Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk Res 8(3):323

    Article  CAS  PubMed  Google Scholar 

  56. Stevenson FK, George AJ, Walters MT, Hamblin TJ (1986) Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods 86:187

    Article  CAS  PubMed  Google Scholar 

  57. Finardi E, Granier E, Tola MR, Melchiorri L, Vaghi L, Rizzo R, Castellazzi M, Ceruti S, Paolino E, Baricordi OR (2002) Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules. J Neuroimmunol 133:151

    Article  PubMed  Google Scholar 

  58. Filaci G, Contini P, Brenci S, Gazzola P, Lanza L, Scudeletti M, Indiveri F, Mancardi GL, Puppo F (1997) HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum Immunol 54(1):54

    Article  CAS  PubMed  Google Scholar 

  59. Stevenson FK, Douglas WA, Spellerberg MB, Walters MT, Cawley MI (1990) Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol 80:32

    CAS  PubMed  Google Scholar 

  60. Adamashvili I, Pressly T, Gebel H, Milford E, Wolf R, Mancini M, Sittg K, Ghali GE, Hall V, McDonald JC (2002) Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Rheumatol Int 22:71–76

    Article  CAS  PubMed  Google Scholar 

  61. Kamada N (1985) The immunology of experimental liver transplantation in the rat. Immunology 55(3):369

    CAS  PubMed  Google Scholar 

  62. Davies HS, Pollard SG, Calne RY (1989) Soluble HLA antigens in the circulation of liver graft patients. Transplantation 47(3):524

    CAS  PubMed  Google Scholar 

  63. Tsuji K, Kusama M, Nakatsuji T et al (1985) Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 10(2–3):169

    Google Scholar 

  64. Liem LM, Koelman CA, Doxiadis II, van Houwelingen JC, Goulmy E, Claas FH (1997) Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transplant 20(3):227

    Article  CAS  PubMed  Google Scholar 

  65. Rhynes VK, McDonald JC, Gelder FB, Aultman DF, Hayes JM, McMillan RW, Mancini MC (1993) Soluble HLA class I in the serum of transplant recipients. Ann Surg 217(5):485

    Google Scholar 

  66. Zavazava N, Bottcher H, Ruchholtz WM (1993) Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 42(1):20

    CAS  PubMed  Google Scholar 

  67. Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ghio M, Scudeletti M, Barocci S, Valente U, Indiveri F (1995) HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 40(3):166

    Article  Google Scholar 

  68. Molajoni ER, Puppo F, Brenci S, Scudeletti M, Cinti P, Alfani D, Indiveri F, Cortesini R (1995) Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation. Transplant Proc 27(1):1155

    PubMed  Google Scholar 

  69. McMillan RM, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, MacDonald JC (1998) Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin Transplant 11:98

    Google Scholar 

  70. Pollard SG, Davies HS, Calne RY (1989) Soluble HLA antigens in human bile. Transplantation 48(4):712

    CAS  PubMed  Google Scholar 

  71. Pollard SG, Davies HF, Calne RY (1990) Preoperative appearance of serum class I antigen during liver transplantation. Transplantation 49(3):659

    CAS  PubMed  Google Scholar 

  72. McDonald JC, Adamashvili I, Zibari GB, Aultman DF, Mancini MC, McMillan RW, Gelder FB (1997) Serologic allogeneic chimerism. Transplantation 64(6):865

    Article  CAS  PubMed  Google Scholar 

  73. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ (1994) Monitoring of kidney and simultaneous pancreas–kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40(3):191

    Article  CAS  PubMed  Google Scholar 

  74. Smith MA, Naziruddin B, Poindexter NJ, Haynes AE, Howard T, Mohanakumar T (2000) Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis. Transplantation 15; 69(1):157

    Article  Google Scholar 

  75. Haga JA, Riley WJ, Kao KJ (1991) Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma. Hum Immunol 32(2):79

    Article  CAS  PubMed  Google Scholar 

  76. Rebmann V, Passler M, Erhard J, Lange R, Eigler FW, Grosse-Wilde H (1999) Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol 60(5):424

    Article  CAS  PubMed  Google Scholar 

  77. Adamashvili I, Kelley R, Zibari G, Aultman D, Sittig K, Mancini M, Smith L, Minagar A, Takemoto S (2004) Variable forms of HLA class I molecules in serum of liver transplant recipients. Tex Med 16:44

    Google Scholar 

  78. Reed E, Beer AE, Hutcherson H, King DW, Suciu-Foca N (1991) The alloantibody response of pregnant women and its suppression by soluble HLA antigens and anti-idiotypic antibodies. J Reprod Immunol 20(2):115

    CAS  PubMed  Google Scholar 

  79. King DW, Reed E, Suciu-Foca N (1989) Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol Res 8(4):249

    CAS  PubMed  Google Scholar 

  80. Kamada N, Shinomiya T (1985) Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 55(1):85

    CAS  PubMed  Google Scholar 

  81. Guencheva G, Scholz S, Schiessl B, Albert ED (1982) Soluble HLA antigens in normal human immunoglobulin preparations. Tissue Antigens 19(3):198

    CAS  PubMed  Google Scholar 

  82. Gross-Wilde H, Blasczyk R, Westhoff U (1992) Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens 39(2):74

    PubMed  Google Scholar 

  83. Santoso S, Kiefel V, Volz H, Mueller-Eckhardt C (1992) Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid-phase immunoassay. Vox Sang 62(1):29

    CAS  PubMed  Google Scholar 

  84. Westhoff U, Grosse-Wilde H (1995) Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 68(2):73

    CAS  PubMed  Google Scholar 

  85. Sumimoto R, Kamada N (1990) Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50(4):678

    CAS  PubMed  Google Scholar 

  86. Krensky AM (1994) T cells in autoimmune and allograft rejection. Kidney Int Suppl 44:S50

    CAS  PubMed  Google Scholar 

  87. Krensky AM, Clayberger C (1995) HLA-derived peptides as novel immunotherapeutics. Clin Immunol Pathol 75(2):112

    Google Scholar 

  88. Krensky AM, Clayberger C (1995) Human leukocyte antigen-derived peptides as novel immunosuppressives. Proc Assoc Am Physicians 107(1):81

    CAS  PubMed  Google Scholar 

  89. Claus R, Hausmann S, Zavazava N, Walzel H, Schulze HA, Kohler H, Friemel H, Muller-Ruchholtz W (1994) In vitro effects of solubilized HLA-DR—role in immunoregulation? Cell Immunol 155(2):476

    Google Scholar 

  90. Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, Newsom-Davis J (1994) Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 93(4):1361

    CAS  PubMed  Google Scholar 

  91. Pri R, Lee J, Shih N, Chen M, Terasaki PI (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 15 (1):43

    Google Scholar 

  92. Zavazava N, Kronke M (1996) Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 2(9):1005

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Louisiana State University Medical Center, P.O. Box 33932, Shreveport, LA, 71130, USA

    Irena Adamashvili, Roger E. Kelley, Thomas Pressly & John C. McDonald

Authors
  1. Irena Adamashvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger E. Kelley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Pressly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John C. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irena Adamashvili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adamashvili, I., Kelley, R.E., Pressly, T. et al. Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients. Rheumatol Int 25, 491–500 (2005). https://doi.org/10.1007/s00296-005-0585-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0585-y

Keywords

Search

Navigation